These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36317865)

  • 1. Studies on Almond Gum and Gelucire-Based Pellets Prepared by Extrusion and Spheronization for Sustained Release.
    Kanteti RV; Sarheed O; Yadav H; Islam Q; Boateng J
    Turk J Pharm Sci; 2022 Oct; 19(5):521-529. PubMed ID: 36317865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.
    Mallipeddi R; Saripella KK; Neau SH
    Saudi Pharm J; 2014 Sep; 22(4):360-72. PubMed ID: 25161381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery.
    Raval MK; Ramani RV; Sheth NR
    Int J Pharm Investig; 2013 Oct; 3(4):203-11. PubMed ID: 24350040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets:
    Alagili MF; AlQuadeib BT; Ashri LY; Ibrahim MA
    Saudi Pharm J; 2023 Aug; 31(8):101690. PubMed ID: 37457369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
    Yan X; He H; Meng J; Zhang C; Hong M; Tang X
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Gelucire
    Shinde UK; Suryawanshi DG; Amin PD
    AAPS PharmSciTech; 2021 Jun; 22(5):182. PubMed ID: 34129146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
    Chopra S; Venkatesan N; Betageri GV
    Int J Pharm; 2013 Mar; 446(1-2):136-44. PubMed ID: 23422274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug.
    Zeeshan F; Peh KK; Tan YT
    AAPS PharmSciTech; 2009; 10(3):850-7. PubMed ID: 19554454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization.
    Garekani HA; Dolatabadi R; Akhgari A; Abbaspour MR; Sadeghi F
    Iran J Basic Med Sci; 2017 Jan; 20(1):9-16. PubMed ID: 28133518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation.
    Shimpi S; Chauhan B; Mahadik KR; Paradkar A
    AAPS PharmSciTech; 2004 Jul; 5(3):e43. PubMed ID: 15760076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
    Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function.
    Singh G; Pai RS; Devi VK
    J Young Pharm; 2012 Jul; 4(3):146-56. PubMed ID: 23112533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization.
    Akhgari A; Abbaspour MR; Pirmoradi S
    Daru; 2011; 19(6):417-23. PubMed ID: 23008687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
    Zhang X; Tang X; Yang R
    Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a solid self-nanoemulsifying drug delivery system for loratadin by extrusion-spheronization.
    Abbaspour M; Jalayer N; Sharif Makhmalzadeh B
    Adv Pharm Bull; 2014; 4(2):113-9. PubMed ID: 24511474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.